</pre> ATAI To Take On Opioid Crisis With Acquisition  The Details:  Atai Life Sciences, a “platform” for psychedelic research and development, has acquired a majority stake in Kures a New York based pharmaceutical company targeting … Continue reading Briefing July 20th: Growing Portfolios